PredictImmune

Recent papers from PredictImmune

1. Killer Immunoglobulin-Like Receptor Haplotypes, Fetal Hla-C2 Exposure, and Immune Dysregulation in Recurrent Pregnancy Loss Patients Undergoing Comprehensive Reproductive and Immunologic EvaluationNorth American Proceedings in Gynecology and Obstetrics - Supplemental · 2026
2. Assessment of PredictSURE IBD Assay in a Multinational Cohort of Patients With Inflammatory Bowel DiseaseUnited European Gastroenterology Journal · 2025
3. A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial˜The œLancet. Gastroenterology & hepatology · 2024
4. Personalised medicine for Crohn’s disease is a cost-effective strategy2022
5. Optimization of RNA extraction from laser captured microdissected glomeruli from formalin-fixed paraffin-embedded mouse kidney samples for Nanostring analysis.2020
6. A blood-based prognostic biomarker in IBDGut · 2019
7. Tezepelumab, an anti–thymic stromal lymphopoietin monoclonal antibody, in the treatment of moderate to severe atopic dermatitis: A randomized phase 2a clinical trialJournal of the American Academy of Dermatology · 2018
8. PRedicting Outcomes For Crohn’s dIsease using a moLecular biomarkEr (PROFILE): protocol for a multicentre, randomised, biomarker-stratified trialBMJ Open · 2018
9. Pharmacodynamic biomarkers and differential effects of TNF ‐ and GM ‐ CSF ‐targeting biologics in rheumatoid arthritisInternational Journal of Rheumatic Diseases · 2018
10. Biological exacerbation clusters demonstrate asthma and chronic obstructive pulmonary disease overlap with distinct mediator and microbiome profilesJournal of Allergy and Clinical Immunology · 2018
11. Radiation and PD-(L)1 treatment combinations: immune response and dose optimization via a predictive systems modelJournal for ImmunoTherapy of Cancer · 2018
12. A randomized, placebo-controlled, single ascending-dose study to assess the safety, tolerability, pharmacokinetics, and immunogenicity of subcutaneous tralokinumab in Japanese healthy volunteersDrug Metabolism and Pharmacokinetics · 2017
13. Tezepelumab in Adults with Uncontrolled AsthmaNew England Journal of Medicine · 2017
14. Optoacoustic Detection of Early Therapy-Induced Tumor Cell Death Using a Targeted Imaging AgentClinical Cancer Research · 2017
15. Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn’s Disease: A Phase 2a StudyGastroenterology · 2017
16. Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug DiscoveryCancer Immunology Research · 2016
17. The Expression of Inflammatory Mediators in Bladder Pain SyndromeEuropean Urology · 2016
18. Pharmacokinetics of tralokinumab in adolescents with asthma: implications for future dosingBritish Journal of Clinical Pharmacology · 2015
19. A high density of tertiary lymphoid structure B cells in lung tumors is associated with increased CD4⁺T cell receptor repertoire clonalityOncoImmunology · 2015
20. Acoustic Dispensing Preserves the Potency of Therapeutic Peptides throughout the Entire Drug Discovery WorkflowSLAS TECHNOLOGY · 2015